For best experience please turn on javascript and use a modern browser!
You are using a browser that is no longer supported by Microsoft. Please upgrade your browser. The site may not present itself correctly if you continue browsing.
Bekijk de site in het Nederlands

The aim of Taina Mattila’s research is to highlight some of the current challenges in schizophrenia research and to demonstrate how analyses on raw study data from drug registration trials can answer a variety of related research questions and aid decision-making in regulatory and clinical practice. She uses individual patient data from 22 double-blind, randomised and placebo-controlled studies into the effect and safety of treatment for patients with schizophrenia.

Event details of From drug registration trials to meaningful clinical evidence
Date 7 July 2016
Time 10:00 -11:00
Location Agnietenkapel
Room Location

T.K. Mattila: Bridging from Drug Registration Trials to Meaningful Clinical Evidence – The Case of Schizophrenia.

Supervisors

Prof. D.A.J.P. Denys

Prof. H.G.M. Leufkens (University of Utrecht)

Co-supervisors

Dr T.D. Wohlfarth (College ter Beoordeling Geneesmiddelen)

Dr M.W.J. Koeter

Agnietenkapel

Room Location

Oudezijds Voorburgwal 229 - 231
1012 EZ Amsterdam

Entrance

This event is open to the public.